Voso, Maria Teresa

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Bernard, E., Tuechler, H., Greenberg, P. L., Hasserjian, R. P., Arango Ossa, J. E., Nannya, Y., Devlin, S. M., Creignou, M., Pinel, P., Monnier, L., et al. (2022) · NEJM Evidence

Acute Myeloid Leukemia ResearchRetinoids in leukemia and cellular processes

Cited by 867

Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

Bernard, E., Nannya, Y., Hasserjian, R. P., Devlin, S. M., Tuechler, H., Medina-Martinez, J. S., Yoshizato, T., Shiozawa, Y., Saiki, R., Malcovati, L., et al. (2020) · Nature Medicine

Acute Myeloid Leukemia ResearchCancer-related Molecular Pathways

Cited by 648

PU.1 (Spi-1) and C/EBPα Regulate Expression of the Granulocyte-Macrophage Colony-Stimulating Factor Receptor α Gene

Hohaus, S., Petrovick, M. S., Voso, M. T., Sun, Z., Zhang, D.-E., & Tenen, D. G. (1995) · Molecular and Cellular Biology

Genomics and Chromatin DynamicsCytokine Signaling Pathways and Interactions

Cited by 284

Therapy-related leukemia and myelodysplasia: susceptibility and incidence

Leone, G., Pagano, L., Ben-Yehuda, D., & Voso, M. T. (2007) · Haematologica

Acute Myeloid Leukemia ResearchMultiple and Secondary Primary Cancers

Cited by 236

Inhibition of hematopoiesis by competitive binding of transcription factor PU.1

Voso, M. T., Burn, T. C., Wulf, G., Lim, B., Leone, G., & Tenen, D. G. (1994) · Proceedings of the National Academy of Sciences

Hematopoietic Stem Cell TransplantationGenomics and Chromatin Dynamics

Cited by 141

Anemia in Hodgkin's Lymphoma: The Role of Interleukin-6 and Hepcidin

Hohaus, S., Massini, G., Giachelia, M., Vannata, B., Bozzoli, V., Cuccaro, A., D'Alo', F., Larocca, L. M., Raymakers, R. A. P., Swinkels, D. W., et al. (2010) · Journal of Clinical Oncology

Iron Metabolism and DisordersLymphoma Diagnosis and Treatment

Cited by 110

A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for higher-risk myelodysplastic syndromes

Zeidan, A. M., Boss, I., Beach, C. L., Copeland, W. B., Thompson, E., Fox, B. A., Hasle, V. E., Ogasawara, K., Cavenagh, J., Silverman, L. R., et al. (2022) · Blood Advances

Acute Myeloid Leukemia ResearchCancer Immunotherapy and Biomarkers

Cited by 61

Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin

Tisi, M. C., Bozzoli, V., Giachelia, M., Massini, G., Ricerca, B. M., Maiolo, E., D’Alo’, F., Larocca, L. M., Piciocchi, A., Tjalsma, H., et al. (2014) · Leukemia & Lymphoma

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 59

Somatic mutations as markers of outcome after azacitidine and allogeneic stem cell transplantation in higher-risk myelodysplastic syndromes

Falconi, G., Fabiani, E., Piciocchi, A., Criscuolo, M., Fianchi, L., Lindfors Rossi, E. L., Finelli, C., Cerqui, E., Ottone, T., Molteni, A., et al. (2019) · Leukemia

Acute Myeloid Leukemia ResearchHematopoietic Stem Cell Transplantation

Cited by 39